Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-12, Stock:JNJ, The news for the past five days is as follows:
2019-07-05: NEWS1: June jobs report crushes expectations as Fed weighs a rate cut.NEWS2: VYM, JNJ, T, CMCSA: Large Inflows Detected at ETF.NEWS3: VYM, JNJ, T, CMCSA: Large Inflows Detected at ETF.NEWS4: Big Blue Could Join NOBL Dividend ETF Next Year.NEWS5: Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency.NEWS6: Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency.NEWS7: Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency.NEWS10: Kellogg is sitting on a ‘fake meat’ gold mine bigger than Beyond Meat.
2019-07-08: NEWS1: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS2: Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?.NEWS3: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN.
2019-07-09: NEWS1: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS2: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS3: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS4: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS5: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS6: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS7: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS8: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS9: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS10: Judge rules against Trump on drug pricing disclosures.NEWS11: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS12: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS13: Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?.NEWS14: Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?.NEWS15: Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status.NEWS16: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Intra-Cellular Therapies' Candidate Fails in Phase III Study.NEWS19: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS20: With new execs on board, Celsius signs Janssen deal.NEWS21: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS22: J&J and Microsoft Among Defensive Stocks With Positive Earnings Outlooks.
2019-07-10: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Johnson & Johnson Wins New Trial In Talc Case.NEWS3: Is Shopify Stock Getting Ahead of Its Fundamentals?.NEWS4: The 10 Biggest Healthcare Stocks.NEWS5: Dow Movers: HD, AXP.NEWS6: Dow Movers: HD, AXP.NEWS7: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Late Surge Helps S&P Join NASDAQ in the Green.NEWS10: Johnson & Johnson submits Jacksonville expansion plans.NEWS11: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS12: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.
2019-07-11: NEWS1: These ETFs make investing easy — even if you’re broke.NEWS2: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS3: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS4: Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer.NEWS5: 4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal.NEWS6: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS7: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS8: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS11: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019.NEWS12: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS13: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS14: UPDATE 1-Eli Lilly's bio-medicines head to leave next month.NEWS15: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS16: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS17: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.

Answer: Decrease